*Chu Guo¹, Shinya Fujii¹, Yuko Imamura¹, Keiya Akamine¹, Miki Bundo¹, Yutaka Nakachi¹, Kimi Araki², Kazuya Iwamoto¹ (1. Department of Molecular Brain Science, Graduate School of Medical Sciences, Kumamoto University, 2. Division of Developmental Genetics, Institute of Resource Development and Analysis, Kumamoto University)

*Chisato Wakabayashi^1,2, Hiroshi Kunugi^1,3 (1. Department of Mental Disorder Research, National Institute of Neuroscience, NCNP, Tokyo, Japan, 2. Faculty of Pharmaceutical Sciences, Himeji Dokkyo University, Hyogo, Japan, 3. Department of Psychiatry, Teikyo University School of Medicine, Tokyo, Japan)

*Yoonjeong Jang^1,2, Sanghyeon Park^1,3, Hong-Hee Won^3,4, Woojae Myung^1,5 (1. Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seoul, South Korea , 2. Department of Health Science and Technology, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, South Korea, 3. Department of Digital Health, Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Samsung Medical Center, Seoul, South Korea, 4. Samsung Genome Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, 5. Department of Psychiatry, Seoul National University, College of Medicine, Seoul, South Korea)

*Ran Wang^1,2, Shuqi Xu^1,2, Xue Yang^1,2, Lihuan Jiao^1,2 (1. Department of Psychiatry,The First Hospital of Hebei Medical University, 2. Mental Health center of Hebei Medical University)